SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-15-000271
Filing Date
2015-11-16
Accepted
2015-11-16 16:07:14
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 sept1510qproctectvedgar4.htm 10-Q 221329
2 exhibit311.htm EX-31 9446
3 exhibit321.htm EX-32 4700
  Complete submission text file 0001551163-15-000271.txt   660361

Data Files

Seq Description Document Type Size
4 prtt-20150930.xml EX-101.INS 32427
5 prtt-20150930.xsd EX-101.SCH 9401
6 prtt-20150930_cal.xml EX-101.CAL 9092
7 prtt-20150930_def.xml EX-101.DEF 6720
8 prtt-20150930_lab.xml EX-101.LAB 53999
9 prtt-20150930_pre.xml EX-101.PRE 43950
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 151234404
SIC: 2834 Pharmaceutical Preparations